Sanofi’s flu vaccine antitrust commitments market-tested by EU Commission
MLex Summary: Parties interested in Sanofi's proposal to make changes to how it communicates about flu vaccine Fluad — with a view to ending a dominance-abuse probe into concerns that Sanofi...To view the full article, register now.
Already a subscriber? Click here to view full article